drugset / Trial / NCT04970836
The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort
Recruiting
240 enrolled
National Taiwan University Hospital
Academia Sinica, Taiwan · collabMinistry of Science and Technology, Taiwan · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer\<10 mIU/mL) need to take.
Timeline
- Start
- 2021-08-01
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Engerix-B | Vaccine | — | — |